Niskayuna, NY, United States of America

Peter Brian Iveson

This inventor holds 1 USPTO granted patent. Top assignee: Affibody Ab. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Brian Iveson. Retrieved from https://idiyas.com/inventor/peter-brian-iveson-n12xqhns

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Peter Brian Iveson: Innovator in HER2 Binders

Introduction

Peter Brian Iveson is a notable inventor based in Niskayuna, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of HER2 binders. His work has implications for cancer treatment, showcasing the importance of innovation in medical research.

Latest Patents

Peter Brian Iveson holds a patent for HER2 binders. This patent represents a crucial advancement in targeted therapies for patients with HER2-positive cancers. With 1 patent to his name, Iveson's work exemplifies the impact that a single innovation can have on the medical community.

Career Highlights

Iveson is currently associated with Affibody AB, a company known for its focus on developing innovative therapeutics. His role at Affibody AB allows him to contribute to cutting-edge research and development in the field of biopharmaceuticals. His expertise in HER2 binders positions him as a key player in the ongoing fight against cancer.

Conclusion

Peter Brian Iveson is a dedicated inventor whose work in HER2 binders is paving the way for advancements in cancer treatment. His contributions highlight the vital role of innovation in improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…